Uber Das Imzaumhalten Der Ausgaben Fur Das Gesundheitswesen:
Erfahrungen in Frankreich, Deutschland, und Japan
HRD-92-9ES-G: Published: Nov 15, 1991. Publicly Released: Nov 15, 1991.
Additional Materials:
- Full Report:
Contact:
Pursuant to a congressional request, GAO reviewed aspects of the health care systems of France, Germany, and Japan, focusing on: (1) their methods of providing universal coverage through their health insurance and financing system; (2) their policies for controlling increases in health care spending; and (3) the effectiveness of those policies.
GAO found that: (1) in France, Germany, Japan and the United States, medical care is provided by private physicians and by both private and public hospitals, patients have free choice of a physician, most people receive health insurance coverage through their work place, and health insurance is provided by multiple third-party insurers; (2) France, Germany, and Japan require insurers to provide minimum coverage that includes a wide range of health care benefits; (3) in the three countries reviewed, insurance enrollment is compulsory for all residents and work-place-based insurance is financed not by premiums that reflect each individual group's expected costs of care, but by employer and employee payroll contributions that reflect the average cost of a larger cross section of the population; (4) all three countries standardize reimbursement rates for almost all physicians and hospitals and set price controls on those rates; (5) although budget controls that augment price controls by setting limits on overall spending for hospital care or for physician services can moderate spending growth, those controls do not ensure high quality care or efficient delivery of services; (6) each of the three countries set limits on overall health spending, but only France and Germany enforced policies to ensure compliance with the limits; (7) between 1984 and 1987, French budget controls reduced real hospital spending by as much as 9 percent, compared with what would have been spent if it had only used price controls; and (8) there was no evidence in the three countries of a decline in broad measurers of health status during the relatively brief period that budget controls were in effect.
Mar 1, 2021
-
Medicare Part B:
Payments and Use for Selected New, High-Cost DrugsGAO-21-252: Published: Mar 1, 2021. Publicly Released: Mar 1, 2021.
Feb 24, 2021
-
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021. -
Health Care Funding:
Federal Obligations to and Funds Received by Certain Organizations Involved in Health-Related Services, 2016 through 2018GAO-21-188R: Published: Dec 21, 2020. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here